This edition of the Patient Worthy Editor’s Choice is coming to you a little early this week. If you’re reading from the United States, we hope you enjoy the holiday weekend and get in some socially distanced fun and relaxation. Up first, we have details on a new study that has helped to improve the understanding of cancer complexity. We also have information about an oral octreotide recently approved by the FDA to treat acromegaly, a disorder involving growth hormone. Finally, we’ve got some tips from the National MS Society for getting a better night’s sleep while living with multiple sclerosis. We hope you have a great weekend!
One of the study’s group leaders commented that this finding may show how cancer cells build resistance to chemotherapy drugs.
Now, patients with acromegaly have the option for less challenging and time-consuming therapeutic options.
60% of all those diagnosed with multiple sclerosis also suffer from some form of sleep disorder.